|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.61 USD | +0.32% |
|
+9.16% | +32.40% |
| 01-16 | RBC Capital Adjusts Price Target on Chemours to $18 From $16, Maintains Outperform Rating | MT |
| 01-15 | The Chemours Company agrees to sell former titanium dioxide site in Taiwan | RE |
| Capitalization | 2.34B 2.02B 1.88B 1.75B 3.25B 212B 3.5B 21.6B 8.52B 101B 8.77B 8.59B 370B | P/E ratio 2025 * |
-7.29x | P/E ratio 2026 * | 9.46x |
|---|---|---|---|---|---|
| Enterprise value | 5.8B 5B 4.65B 4.33B 8.06B 526B 8.68B 53.51B 21.1B 251B 21.74B 21.29B 916B | EV / Sales 2025 * |
1x | EV / Sales 2026 * | 0.94x |
| Free-Float |
74.8% | Yield 2025 * |
3.25% | Yield 2026 * | 2.25% |
Last Transcript: The Chemours Company
| 1 day | +0.32% | ||
| 1 week | +9.16% | ||
| Current month | +32.40% | ||
| 1 month | +31.51% | ||
| 3 months | +21.01% | ||
| 6 months | +15.12% | ||
| Current year | +32.40% |
| 1 week | 14.31 | 16.58 | |
| 1 month | 11.68 | 16.58 | |
| Current year | 11.83 | 16.58 | |
| 1 year | 9.13 | 20.12 | |
| 3 years | 9.13 | 39.05 | |
| 5 years | 9.13 | 44.95 | |
| 10 years | 3.06 | 58.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Denise Dignam
CEO | Chief Executive Officer | 60 | 27/02/2024 |
Shane Hostetter
DFI | Director of Finance/CFO | 45 | 30/06/2024 |
Brandon Ontjes
IRC | Investor Relations Contact | - | 26/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Mary Cranston
CHM | Chairman | 78 | 01/09/2025 |
Sean Keohane
BRD | Director/Board Member | 59 | 31/12/2017 |
Erin Kane
BRD | Director/Board Member | 49 | 17/06/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.32% | +9.16% | -19.54% | -52.83% | 2.34B | ||
| -1.25% | +3.21% | +8.87% | +67.23% | 67.44B | ||
| -3.67% | -0.78% | +0.34% | -16.07% | 45.71B | ||
| -1.25% | -0.52% | +4.97% | +18.67% | 16.56B | ||
| -0.79% | +2.81% | +44.89% | +60.30% | 13.02B | ||
| -0.13% | +0.15% | +16.16% | +39.59% | 9.89B | ||
| -1.53% | +3.10% | +28.60% | +43.58% | 8.73B | ||
| -2.88% | +1.55% | -2.44% | - | 8.53B | ||
| -3.97% | +0.74% | -10.49% | -25.69% | 8.43B | ||
| 0.00% | -1.28% | -1.96% | -6.10% | 5.49B | ||
| Average | -1.52% | +3.29% | +6.94% | +14.30% | 18.61B | |
| Weighted average by Cap. | -1.91% | +4.72% | +8.19% | +29.79% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.8B 5B 4.66B 4.33B 8.07B 526B 8.68B 53.55B 21.11B 251B 21.75B 21.3B 917B | 6.03B 5.2B 4.84B 4.51B 8.4B 548B 9.03B 55.71B 21.97B 261B 22.63B 22.17B 954B |
| Net income | -328M -282M -263M -245M -456M -29.72B -490M -3.02B -1.19B -14.17B -1.23B -1.2B -51.76B | 252M 217M 202M 188M 351M 22.86B 377M 2.33B 917M 10.91B 945M 926M 39.82B |
| Net Debt | 3.46B 2.98B 2.77B 2.58B 4.81B 314B 5.17B 31.91B 12.58B 150B 12.96B 12.69B 546B | 3.32B 2.86B 2.66B 2.48B 4.61B 301B 4.96B 30.62B 12.07B 144B 12.44B 12.18B 524B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 15.61 $ | +0.32% | 5,305,227 |
| 15/01/26 | 15.56 $ | +4.01% | 3,437,567 |
| 14/01/26 | 14.96 $ | +1.84% | 3,743,213 |
| 13/01/26 | 14.69 $ | -0.20% | 2,503,041 |
| 12/01/26 | 14.72 $ | +2.94% | 3,440,222 |
Delayed Quote Nyse, January 16, 2026 at 09:00 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















